Infectious Diseases in Children Current Issue

The following articles appeared in the print edition of Infectious Diseases in Children.

Table of Contents

• Pediatric ID compensation ‘just too low’
• Acyclovir labeling now includes premature infants with HSV
• Antibiotic diversion poses serious health risks
• Causes of 2014 EV-D68 outbreak still unknown
• Early estimates show flu vaccine 47% effective in US
• Guideline urges physicians to stop prescribing antibiotics, codeine for tonsillectomies
• Measles cases in Europe tripled in 2018, WHO says
• Nearly 80% of children began toothbrushing later than recommended
• Parents understand cold prevention; most still use unproven strategies
• What is the value of the pediatric ID specialty?
• Q&A: Should pediatricians suggest probiotics to reduce abdominal pain?
• 25% of sepsis cases following PCV13 introduction caused by S. pneumoniae
• Almost 16% of pediatric transplant recipients hospitalized with vaccine-preventable diseases
• Buprenorphine optimal treatment for neonatal abstinence syndrome
• Chemical exposure before, after birth reduces lung function
• Continuous vancomycin infusions in infants result in earlier, improved target concentrations
• Decision tree promotes correct antibiotic prescribing for bloodstream infections
• Half of US children with mental health disorders are not treated
• Light aerobic activity improves concussion recovery time
• Only 16% of teens complete HPV vaccine series by age 13 years
• Palivizumab not effective treatment for RSV bronchiolitis
• Parents collect respiratory samples earlier in illness than HCWs
• Researchers identify factors associated with recurrent tonsillitis
• Study shows ‘significant disparities’ in global fatality rates from sepsis
• Pediatric implications of Xofluza — a new antiviral drug for influenza Edward A. Bell, PharmD, BCPS
• 3-year-old female presents with lesion that doubles in size James H. Brien, DO